Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$78.61

-1.41 (-1.76%)

12:14
02/21/19
02/21
12:14
02/21/19
12:14
Hot Stocks
AbbVie reaches agreement with pan-Canadian Pharmaceutical Alliance »

AbbVie announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

ABBV

AbbVie

$80.02

-0.48 (-0.60%)

05:43
02/21/19
02/21
05:43
02/21/19
05:43
Recommendations
AbbVie analyst commentary at Piper Jaffray »

Piper doctor surveys show…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

Yesterday
AMGN

Amgen

$186.97

-1.34 (-0.71%)

, ABBV

AbbVie

$80.50

-0.35 (-0.43%)

07:50
02/20/19
02/20
07:50
02/20/19
07:50
Recommendations
Amgen, AbbVie, Novartis analyst commentary at Morgan Stanley »

Amgen could fall over 10%…

AMGN

Amgen

$186.97

-1.34 (-0.71%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

NVS

Novartis

$89.95

0.06 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 28

    Feb

  • 05

    Mar

  • 18

    Mar

  • 19

    Mar

  • 18

    May

Tuesday
TEVA

Teva

$18.01

0.02 (0.11%)

, AGN

Allergan

$137.94

-1.13 (-0.81%)

18:26
02/19/19
02/19
18:26
02/19/19
18:26
Hot Stocks
Teva finalizes settlement with FTC to resolve all outstanding litigation »

Teva Pharmaceutical…

TEVA

Teva

$18.01

0.02 (0.11%)

AGN

Allergan

$137.94

-1.13 (-0.81%)

ABBV

AbbVie

$80.50

-0.35 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 22

    Feb

  • 25

    Feb

  • 18

    May

  • 28

    May

ABBV

AbbVie

$80.85

0.355 (0.44%)

08:33
02/19/19
02/19
08:33
02/19/19
08:33
Hot Stocks
AbbVie announces FDA accepted for priority review NDA for upadacitinib »

AbbVie has announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

Over a week ago
UAA

Under Armour

$20.78

(0.00%)

, COTY

Coty

$9.67

(0.00%)

09:40
02/12/19
02/12
09:40
02/12/19
09:40
Options
Unusually active option classes on open February 12th »

Unusual total active…

UAA

Under Armour

$20.78

(0.00%)

COTY

Coty

$9.67

(0.00%)

EA

Electronic Arts

$97.27

(0.00%)

SHOP

Shopify

$172.99

(0.00%)

GILD

Gilead

$67.63

(0.00%)

ACB

Aurora Cannabis

$7.17

(0.00%)

ATVI

Activision Blizzard

$40.11

(0.00%)

ABBV

AbbVie

$79.77

(0.00%)

CTL

CenturyLink

$14.10

(0.00%)

TWLO

Twilio

$115.69

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 12

    Feb

  • 13

    Feb

  • 14

    Feb

  • 25

    Feb

  • 03

    Mar

  • 18

    Mar

  • 18

    May

ABBV

AbbVie

$79.69

0.5 (0.63%)

08:04
02/11/19
02/11
08:04
02/11/19
08:04
Hot Stocks
AbbVie, Teneobio enter global strategic transaction to develop TNB-383B »

AbbVie, Teneobio, and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    May

NBIX

Neurocrine

$87.90

-0.49 (-0.55%)

07:34
02/06/19
02/06
07:34
02/06/19
07:34
Recommendations
Neurocrine analyst commentary at Cantor Fitzgerald »

Neurocrine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$87.90

-0.49 (-0.55%)

06:08
02/06/19
02/06
06:08
02/06/19
06:08
Recommendations
Neurocrine analyst commentary at Piper Jaffray »

Neurocrine lack of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBIX

Neurocrine

$87.99

-0.4 (-0.45%)

, ABBV

AbbVie

$79.64

1.1 (1.40%)

16:05
02/05/19
02/05
16:05
02/05/19
16:05
Hot Stocks
Neurocrine expects $20M in revenue milestones under the AbbVie agreement in FY19 »

Neurocrine Biosciences…

NBIX

Neurocrine

$87.99

-0.4 (-0.45%)

ABBV

AbbVie

$79.64

1.1 (1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 18

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.